DreamCIS Inc
223250
Company Profile
Business description
DreamCIS Inc operates as a contract research organization. It provides experience services in Therapeutic Areas; Clinical Trial/Late Phase Study; Oncology; Cardiovascular; Endocrinology; and Rare Disease. It provides its services to clinical development; stand alone services; medical devices; and consulting.
Contact
130, Sajik-ro
Jongno-gu
Jeokseon-Hyundai Building, 10th Floor
Seoul
KORT: +82 220104500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Care Facilities
Fiscal Year End
31 December 2026
Employees
372
Stocks News & Analysis
stocks
Hostile takeover on the cards for this ASX income opportunity
IFM lobs reasonable takeover offer.
stocks
Get ready for major US tech earnings starting tomorrow morning
Microsoft, Amazon, Alphabet, and Meta will all release quarterly earnings. Here’s what analysts are looking for.
stocks
Corning’s AI fiber boom is real, but its stock price may be getting out of hand
Corning’s optical fiber business is thriving, and the Meta deal derisks its supply buildout, but success isn’t guaranteed.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,915.70 | 16.00 | 0.18% |
| CAC 40 | 8,071.06 | 33.03 | -0.41% |
| DAX 40 | 24,018.68 | 0.42 | 0.00% |
| Dow JONES (US) | 49,141.93 | 25.86 | -0.05% |
| FTSE 100 | 10,267.22 | 65.57 | -0.63% |
| HKSE | 26,103.64 | 423.86 | 1.65% |
| NASDAQ | 24,663.80 | 223.30 | -0.90% |
| Nikkei 225 | 59,917.46 | 619.90 | -1.02% |
| NZX 50 Index | 12,770.30 | 5.90 | 0.05% |
| S&P 500 | 7,138.80 | 35.11 | -0.49% |
| S&P/ASX 200 | 8,687.00 | 9.40 | 0.11% |
| SSE Composite Index | 4,107.51 | 28.88 | 0.71% |